News

Inflammation plays a key role in the progression of polycythemia vera (PV), making it an important potential treatment target. In a new Perspective article,…

Artificial intelligence (AI) may help design better CAR T-cell therapies to treat myeloma and other cancers, a study showed. An AI-designed CAR…

The U.S. Food and Drug Administration (FDA) has awarded its breakthrough therapy designation — which aims to speed the development of promising new medications —…

Treatment with Tecvayli (teclistamab), an approved cancer drug, can reduce the risk of disease progression in people with high-risk smoldering multiple myeloma, an…

The overall risk of any infection in the first year after starting treatment is similar in people given different types of immune-modulating therapies for…

Bristol Myers Squibb‘s experimental cell therapy arlocabtagene autoleucel (arlo-cel) may help control myeloma that has returned or failed…

A CAR T-cell therapy targeting glioblastoma improved tumor control and survival in mice when given before surgery rather than afterward, according to a new study.

September is Gynecologic Cancer Awareness Month, and advocacy groups are running campaigns to raise awareness about gynecological cancers, raise funds for research, and…

Since the late 1940s, when the first chemotherapies were introduced, advances in treatment for blood cancers have resulted in an estimated 25.8 million life-years…

A novel mRNA vaccine effectively triggered an antitumor immune response in a mouse model of pancreatic cancer, even completely eliminating the cancer in a…